Industry: Service & Software
Published Date: 2025-08-27
Pages: 117 Pages
Report ld: 4938540
Request Sample
Customized Report
Omics Data Analysis Service Market Size(US$)

CAGR 2025-2031
5.9%
Market Size,2031
USD 1,144
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Omics Data Analysis Service was estimated to be worth US$ 745 million in 2024 and is forecast to a readjusted size of US$ 1144 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Omics Data Analysis Service is a service that uses data generated by high-throughput omics technologies (such as sequencing, mass spectrometry, and microarrays) as its core, and combines multi-omics integrated analysis, machine learning, network modeling and other technologies to systematically analyze the composition, structure, function and interactions of biological molecules (DNA, RNA, proteins, metabolites, etc.).
North American market for Omics Data Analysis Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Omics Data Analysis Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Omics Data Analysis Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Omics Data Analysis Service include Acobiom, AltraBio, BGI Genomics, Biogenity, Tempus, Cmbio, Creative Proteomics, Firalis Molecular Precision, Metware Biotechnology, Nuvisan, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Omics Data Analysis Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Omics Data Analysis Service by region & country, by Type, and by Application.
The Omics Data Analysis Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omics Data Analysis Service.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Omics Data Analysis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Omics Data Analysis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Omics Data Analysis Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Omics Data Analysis Service Product Introduction
1.2 Global Omics Data Analysis Service Market Size Forecast (2020-2031)
1.3 Omics Data Analysis Service Market Trends & Drivers
1.3.1 Omics Data Analysis Service Industry Trends
1.3.2 Omics Data Analysis Service Market Drivers & Opportunity
1.3.3 Omics Data Analysis Service Market Challenges
1.3.4 Omics Data Analysis Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Omics Data Analysis Service Players Revenue Ranking (2024)
2.2 Global Omics Data Analysis Service Revenue by Company (2020-2025)
2.3 Key Companies Omics Data Analysis Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Omics Data Analysis Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Omics Data Analysis Service
2.6 Omics Data Analysis Service Market Competitive Analysis
2.6.1 Omics Data Analysis Service Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Omics Data Analysis Service Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Omics Data Analysis Service as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Genomic Analysis
3.1.2 Transcriptomic Analysis
3.1.3 Proteomic Analysis
3.1.4 Metabolomic Analysis
3.1.5 Epigenomic Analysis
3.1.6 Microbiome Analysis
3.1.7 Others
3.2 Global Omics Data Analysis Service Sales Value by Type
3.2.1 Global Omics Data Analysis Service Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Omics Data Analysis Service Sales Value, by Type (2020-2031)
3.2.3 Global Omics Data Analysis Service Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Developmental Biology
4.1.2 Clinical Medicine
4.1.3 Precision Diagnosis
4.1.4 Drug Development
4.1.5 Others
4.2 Global Omics Data Analysis Service Sales Value by Application
4.2.1 Global Omics Data Analysis Service Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Omics Data Analysis Service Sales Value, by Application (2020-2031)
4.2.3 Global Omics Data Analysis Service Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Omics Data Analysis Service Sales Value by Region
5.1.1 Global Omics Data Analysis Service Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Omics Data Analysis Service Sales Value by Region (2020-2025)
5.1.3 Global Omics Data Analysis Service Sales Value by Region (2026-2031)
5.1.4 Global Omics Data Analysis Service Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Omics Data Analysis Service Sales Value, 2020-2031
5.2.2 North America Omics Data Analysis Service Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Omics Data Analysis Service Sales Value, 2020-2031
5.3.2 Europe Omics Data Analysis Service Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Omics Data Analysis Service Sales Value, 2020-2031
5.4.2 Asia Pacific Omics Data Analysis Service Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Omics Data Analysis Service Sales Value, 2020-2031
5.5.2 South America Omics Data Analysis Service Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Omics Data Analysis Service Sales Value, 2020-2031
5.6.2 Middle East & Africa Omics Data Analysis Service Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Omics Data Analysis Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Omics Data Analysis Service Sales Value, 2020-2031
6.3 United States
6.3.1 United States Omics Data Analysis Service Sales Value, 2020-2031
6.3.2 United States Omics Data Analysis Service Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Omics Data Analysis Service Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Omics Data Analysis Service Sales Value, 2020-2031
6.4.2 Europe Omics Data Analysis Service Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Omics Data Analysis Service Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Omics Data Analysis Service Sales Value, 2020-2031
6.5.2 China Omics Data Analysis Service Sales Value by Type (%), 2024 VS 2031
6.5.3 China Omics Data Analysis Service Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Omics Data Analysis Service Sales Value, 2020-2031
6.6.2 Japan Omics Data Analysis Service Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Omics Data Analysis Service Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Omics Data Analysis Service Sales Value, 2020-2031
6.7.2 South Korea Omics Data Analysis Service Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Omics Data Analysis Service Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Omics Data Analysis Service Sales Value, 2020-2031
6.8.2 Southeast Asia Omics Data Analysis Service Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Omics Data Analysis Service Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Omics Data Analysis Service Sales Value, 2020-2031
6.9.2 India Omics Data Analysis Service Sales Value by Type (%), 2024 VS 2031
6.9.3 India Omics Data Analysis Service Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Acobiom
7.1.1 Acobiom Profile
7.1.2 Acobiom Main Business
7.1.3 Acobiom Omics Data Analysis Service Products, Services and Solutions
7.1.4 Acobiom Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.1.5 Acobiom Recent Developments
7.2 AltraBio
7.2.1 AltraBio Profile
7.2.2 AltraBio Main Business
7.2.3 AltraBio Omics Data Analysis Service Products, Services and Solutions
7.2.4 AltraBio Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.2.5 AltraBio Recent Developments
7.3 BGI Genomics
7.3.1 BGI Genomics Profile
7.3.2 BGI Genomics Main Business
7.3.3 BGI Genomics Omics Data Analysis Service Products, Services and Solutions
7.3.4 BGI Genomics Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.3.5 BGI Genomics Recent Developments
7.4 Biogenity
7.4.1 Biogenity Profile
7.4.2 Biogenity Main Business
7.4.3 Biogenity Omics Data Analysis Service Products, Services and Solutions
7.4.4 Biogenity Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.4.5 Biogenity Recent Developments
7.5 Tempus
7.5.1 Tempus Profile
7.5.2 Tempus Main Business
7.5.3 Tempus Omics Data Analysis Service Products, Services and Solutions
7.5.4 Tempus Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.5.5 Tempus Recent Developments
7.6 Cmbio
7.6.1 Cmbio Profile
7.6.2 Cmbio Main Business
7.6.3 Cmbio Omics Data Analysis Service Products, Services and Solutions
7.6.4 Cmbio Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.6.5 Cmbio Recent Developments
7.7 Creative Proteomics
7.7.1 Creative Proteomics Profile
7.7.2 Creative Proteomics Main Business
7.7.3 Creative Proteomics Omics Data Analysis Service Products, Services and Solutions
7.7.4 Creative Proteomics Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.7.5 Creative Proteomics Recent Developments
7.8 Firalis Molecular Precision
7.8.1 Firalis Molecular Precision Profile
7.8.2 Firalis Molecular Precision Main Business
7.8.3 Firalis Molecular Precision Omics Data Analysis Service Products, Services and Solutions
7.8.4 Firalis Molecular Precision Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.8.5 Firalis Molecular Precision Recent Developments
7.9 Metware Biotechnology
7.9.1 Metware Biotechnology Profile
7.9.2 Metware Biotechnology Main Business
7.9.3 Metware Biotechnology Omics Data Analysis Service Products, Services and Solutions
7.9.4 Metware Biotechnology Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.9.5 Metware Biotechnology Recent Developments
7.10 Nuvisan
7.10.1 Nuvisan Profile
7.10.2 Nuvisan Main Business
7.10.3 Nuvisan Omics Data Analysis Service Products, Services and Solutions
7.10.4 Nuvisan Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.10.5 Nuvisan Recent Developments
7.11 Omics Data Solutions
7.11.1 Omics Data Solutions Profile
7.11.2 Omics Data Solutions Main Business
7.11.3 Omics Data Solutions Omics Data Analysis Service Products, Services and Solutions
7.11.4 Omics Data Solutions Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.11.5 Omics Data Solutions Recent Developments
7.12 PharmaLex
7.12.1 PharmaLex Profile
7.12.2 PharmaLex Main Business
7.12.3 PharmaLex Omics Data Analysis Service Products, Services and Solutions
7.12.4 PharmaLex Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.12.5 PharmaLex Recent Developments
7.13 Standard BioTools
7.13.1 Standard BioTools Profile
7.13.2 Standard BioTools Main Business
7.13.3 Standard BioTools Omics Data Analysis Service Products, Services and Solutions
7.13.4 Standard BioTools Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.13.5 Standard BioTools Recent Developments
7.14 PIPA AI
7.14.1 PIPA AI Profile
7.14.2 PIPA AI Main Business
7.14.3 PIPA AI Omics Data Analysis Service Products, Services and Solutions
7.14.4 PIPA AI Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.14.5 PIPA AI Recent Developments
7.15 Seven Bridges
7.15.1 Seven Bridges Profile
7.15.2 Seven Bridges Main Business
7.15.3 Seven Bridges Omics Data Analysis Service Products, Services and Solutions
7.15.4 Seven Bridges Omics Data Analysis Service Revenue (US$ Million) & (2020-2025)
7.15.5 Seven Bridges Recent Developments
8 Industry Chain Analysis
8.1 Omics Data Analysis Service Industrial Chain
8.2 Omics Data Analysis Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Omics Data Analysis Service Sales Model
8.5.2 Sales Channel
8.5.3 Omics Data Analysis Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Omics Data Analysis Service market is projected to grow from US$ 812 million in 2025 to US$ 1205 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 144
USD 4900.00
(Single User License)
The global Omics Data Analysis Service market size was US$ 812 million in 2025 and is forecast to reach a readjusted size of US$ 1205 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 94
USD 4250.00
(Single User License)
The global Omics Data Analysis Service market was valued at US$ 812 million in 2025 and is anticipated to reach US$ 1205 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 120
USD 2900.00
(Single User License)
The global market for Omics Data Analysis Service was estimated to be worth US$ 812 million in 2025 and is projected to reach US$ 1205 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 113
USD 3950.00
(Single User License)
The global market for Omics Data Analysis Service was valued at US$ 745 million in the year 2024 and is projected to reach a revised size of US$ 1144 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-08-27
Pages: 89
USD 2900.00
(Single User License)
The global Omics Data Analysis Service market is projected to grow from US$ 745 million in 2024 to US$ 1144 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-27
Pages: 137
USD 4900.00
(Single User License)
The global Omics Data Analysis Service market size was US$ 745 million in 2024 and is forecast to a readjusted size of US$ 1144 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 92
USD 4250.00
(Single User License)
The global Omics Data Analysis Service market is projected to grow from US$ 812 million in 2025 to US$ 1205 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 144
The global Omics Data Analysis Service market size was US$ 812 million in 2025 and is forecast to reach a readjusted size of US$ 1205 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 94
The global Omics Data Analysis Service market was valued at US$ 812 million in 2025 and is anticipated to reach US$ 1205 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-12
Pages: 120
The global market for Omics Data Analysis Service was estimated to be worth US$ 812 million in 2025 and is projected to reach US$ 1205 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-09
Pages: 113
The global market for Omics Data Analysis Service was valued at US$ 745 million in the year 2024 and is projected to reach a revised size of US$ 1144 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-08-27
Pages: 89
The global Omics Data Analysis Service market is projected to grow from US$ 745 million in 2024 to US$ 1144 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-27
Pages: 137
The global Omics Data Analysis Service market size was US$ 745 million in 2024 and is forecast to a readjusted size of US$ 1144 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 92
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now